drugset / Trial / NCT01102270
The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome
Phase 0
Completed
17 enrolled
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI) · collabSumitomo Pharma America, Inc. · collab
RandomizedCrossoverTriple-blindBasic science
Summary
The purpose of this study is to find out whether taking eszopiclone (Lunesta) changes the breathing effort required to briefly wake people with obstructive sleep apnea from sleep (respiratory arousal threshold). We would like to see if taking eszopiclone can reduce the severity of obstructive sleep apnea in some people (those that have a low respiratory arousal threshold; i.e. wake up easily to respiratory stimuli).
Timeline
- Start
- 2009-01
- Primary completion
- 2009-08
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eszopiclone | Small molecule | 3 mg | — |